首页 > 最新文献

Cirugia y cirujanos最新文献

英文 中文
[Mixed adenoneuroendocrine carcinoma: case report]. [混合性腺内分泌癌:病例报告]
Pub Date : 2024-02-12 DOI: 10.24875/CIRU.21000713
Ángel A Hernández-Moreno, Carlos E Durón-Gutiérrez, Sheyla P Serrano-González, Grettel León-Martínez, José G Arroyo-Del-Castillo

Introducción: Mixed adenoneuroendocrine carcinoma is a rare tumor of the gastrointestinal tract with double differentiation into adenomatous and neuroendocrine carcinoma, each component with at least 30%.

Case report: A 60-year-old female with acute abdominal pain. Surgical treatment was decided, finding a tumor at the level of the cecum and ascending colon, a right hemicolectomy and ileostomy were performed.

Discussion: Mixed adenoneuroendocrine carcinoma can appear in various organs. They are highly malignant tumors, with a high risk of metastasis.

Conclusions: These tumors do not present symptoms or specific radiological or laboratory findings; diagnosis depends on postoperative histopathological and immunohistochemical studies.

介绍:腺神经内分泌混合癌是一种罕见的胃肠道肿瘤,具有腺瘤样癌和神经内分泌癌双重分化,每种成分至少占30%:病例报告:一名 60 岁女性,急性腹痛。决定进行手术治疗,发现肿瘤位于盲肠和升结肠水平,于是进行了右半结肠切除术和回肠造口术:讨论:混合型腺内分泌癌可出现在多个器官。讨论:混合腺神经内分泌癌可出现在多个器官,是高度恶性肿瘤,转移风险高:这些肿瘤没有症状,也没有特殊的放射学或实验室检查结果;诊断取决于术后组织病理学和免疫组化检查。
{"title":"[Mixed adenoneuroendocrine carcinoma: case report].","authors":"Ángel A Hernández-Moreno, Carlos E Durón-Gutiérrez, Sheyla P Serrano-González, Grettel León-Martínez, José G Arroyo-Del-Castillo","doi":"10.24875/CIRU.21000713","DOIUrl":"10.24875/CIRU.21000713","url":null,"abstract":"<p><strong>Introducción: </strong>Mixed adenoneuroendocrine carcinoma is a rare tumor of the gastrointestinal tract with double differentiation into adenomatous and neuroendocrine carcinoma, each component with at least 30%.</p><p><strong>Case report: </strong>A 60-year-old female with acute abdominal pain. Surgical treatment was decided, finding a tumor at the level of the cecum and ascending colon, a right hemicolectomy and ileostomy were performed.</p><p><strong>Discussion: </strong>Mixed adenoneuroendocrine carcinoma can appear in various organs. They are highly malignant tumors, with a high risk of metastasis.</p><p><strong>Conclusions: </strong>These tumors do not present symptoms or specific radiological or laboratory findings; diagnosis depends on postoperative histopathological and immunohistochemical studies.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":" ","pages":"674-678"},"PeriodicalIF":0.0,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical evolution of patients with infection associated with orthopedic devices in treatment with continuous negative pressure]. [持续负压治疗骨科设备相关感染患者的临床演变]。
Pub Date : 2024-02-12 DOI: 10.24875/CIRU.23000248
Jorge Quiroz-Williams, José R Viveros-Encarnación, Suemmy Gaytán-Fernández, Rodolfo G Barragán-Hervella, Carlos R Rueda-Alvarado, América Ramírez-Polanco, M Paloma Martínez-Senda, Andrea M Palma-Jaimes

Objective: To describe the use of negative pressure therapy with (TPNi) and without instillation (TPNs) as adjuvant treatment in the management of orthopedic device-associated infections (IADO).

Method: Analytic observational study of records of patients with IADO managed with TPNi and TPNs with 0.9% saline solution, in patients > 18 years, operated on in 2018-2021. Clinical characteristics of infection, infectious agent as well as sociodemographic variables were evaluated. TPN was performed with the V.A.C. VERAFLO™ system. Analysis with χ2, Fisher and t-Student. Statistically accepted value p < 0.05.

Results: Sample 40 patients. 75% male. Fractures 42.5% exposed and 57.5% closed. 92.5% applied prophylactic antibiotic (30-120 min). 35% plate implants, 12.5% centromedullary nail, 10% knee prosthesis and 12.5% hip. 47.5% bleeding < 500 ml. 72.5% surgical time of 2-4 hours. Previous hospitalization time, TPNs 3 weeks 55.9% and 4 weeks 26.5%; TPNi, 3 weeks 50% and 4 weeks 33.3%. Conservation of the implant 73.5% TPNs and 50% TPNi (p = 0.341). Wound closure 91.2% with TPNs and 100% with TPNi (p = 1.000).

Conclusions: The use of TPNs and TPNi were useful as adjuvant treatments in the management of IADO, in addition they allowed to preserve the implant and wound closure in a large part of the patients.

目的描述在骨科器械相关感染(IADO)治疗中使用负压疗法(TPNi)和不灌注负压疗法(TPNs)作为辅助治疗的情况:对2018-2021年手术的18岁以上IADO患者使用TPNi和0.9%生理盐水TPNs治疗的记录进行分析观察研究。对感染的临床特征、感染病原体以及社会人口学变量进行了评估。TPN使用V.A.C. VERAFLO™系统进行。用χ2、费雪和 t-Student 进行分析。统计学接受值 p < 0.05:样本 40 名患者。男性占 75%。42.5%的骨折为暴露骨折,57.5%为闭合骨折。92.5%应用预防性抗生素(30-120 分钟)。35%植入钢板,12.5%植入髓内钉,10%植入膝关节假体,12.5%植入髋关节假体。47.5%出血量小于 500 毫升。72.5%的手术时间为2-4小时。之前的住院时间,TPNs 3周55.9%,4周26.5%;TPNi,3周50%,4周33.3%。植入物的保存率:73.5%为TPNs,50%为TPNi(P = 0.341)。使用 TPNs 的伤口闭合率为 91.2%,使用 TPNi 的伤口闭合率为 100%(p = 1.000):使用 TPNs 和 TPNi 作为 IADO 的辅助治疗方法非常有用,此外,它们还能保留植入物,并使大部分患者的伤口闭合。
{"title":"[Clinical evolution of patients with infection associated with orthopedic devices in treatment with continuous negative pressure].","authors":"Jorge Quiroz-Williams, José R Viveros-Encarnación, Suemmy Gaytán-Fernández, Rodolfo G Barragán-Hervella, Carlos R Rueda-Alvarado, América Ramírez-Polanco, M Paloma Martínez-Senda, Andrea M Palma-Jaimes","doi":"10.24875/CIRU.23000248","DOIUrl":"https://doi.org/10.24875/CIRU.23000248","url":null,"abstract":"<p><strong>Objective: </strong>To describe the use of negative pressure therapy with (TPNi) and without instillation (TPNs) as adjuvant treatment in the management of orthopedic device-associated infections (IADO).</p><p><strong>Method: </strong>Analytic observational study of records of patients with IADO managed with TPNi and TPNs with 0.9% saline solution, in patients > 18 years, operated on in 2018-2021. Clinical characteristics of infection, infectious agent as well as sociodemographic variables were evaluated. TPN was performed with the V.A.C. VERAFLO™ system. Analysis with χ2, Fisher and t-Student. Statistically accepted value p < 0.05.</p><p><strong>Results: </strong>Sample 40 patients. 75% male. Fractures 42.5% exposed and 57.5% closed. 92.5% applied prophylactic antibiotic (30-120 min). 35% plate implants, 12.5% centromedullary nail, 10% knee prosthesis and 12.5% hip. 47.5% bleeding < 500 ml. 72.5% surgical time of 2-4 hours. Previous hospitalization time, TPNs 3 weeks 55.9% and 4 weeks 26.5%; TPNi, 3 weeks 50% and 4 weeks 33.3%. Conservation of the implant 73.5% TPNs and 50% TPNi (p = 0.341). Wound closure 91.2% with TPNs and 100% with TPNi (p = 1.000).</p><p><strong>Conclusions: </strong>The use of TPNs and TPNi were useful as adjuvant treatments in the management of IADO, in addition they allowed to preserve the implant and wound closure in a large part of the patients.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified extensile calcaneal exposure is safe. 改良的伸展式钙楔暴露是安全的。
Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000580
Chuansheng Fu, Baofu Wei, Hongjian Pei, Cunyin Xue, Jijuan Zhou, Guodong Zhong

Objective: The objective of this study was to evaluate the effect of open reduction and internal fixation for displaced intra-articular calcaneal fractures through a modified tarsal sinus incision.

Methods: A retrospective review over 3 years of the clinical data of patients with intra-articular calcaneal fractures treated with open reduction and internal fixation through lateral hook curvy incisions. The efficacy of the 25 lateral hook curvy incisions was analyzed.

Results: According to the AOFAS hindfoot function scoring criteria, there were 20 excellent (80%), 2 good (8%), 2 fair (8%), and 1 poor patient outcome. The average pre-operative Bohler's angle was 6.8 ± 8.9°, and the average angle at follow-up was 33.6 ± 5.7°. The average pre-operative Gissane angle was 89.2 ± 20.0°, and the average angle at follow-up was 115.5 ± 5.5°.

Conclusions: A lateral hook curvy incision can expose the posterior articular surface of the calcaneus and the calcaneocuboid joint, reduce stripping and pulling of the soft tissue, and avoid calcaneus valgus caused by the pulling of the peroneus tendon.

研究目的本研究旨在评估通过改良的跗骨窦切口对移位的关节内小关节骨折进行切开复位和内固定的效果:方法:回顾性分析关节内小关节骨折患者通过侧钩曲线切口行切开复位内固定术治疗 3 年来的临床数据。分析了25种外侧钩形切口的疗效:根据 AOFAS 后足功能评分标准,患者疗效为优 20 例(80%)、良 2 例(8%)、一般 2 例(8%)、差 1 例。术前 Bohler's 角度平均为 6.8 ± 8.9°,随访时的平均角度为 33.6 ± 5.7°。术前 Gissane 角平均为 89.2 ± 20.0°,随访时的平均角度为 115.5 ± 5.5°:结论:侧钩弧形切口可以暴露小腿后侧关节面和小腿臼关节,减少软组织的剥离和牵拉,避免腓肠肌肌腱牵拉造成的小腿外翻。
{"title":"Modified extensile calcaneal exposure is safe.","authors":"Chuansheng Fu, Baofu Wei, Hongjian Pei, Cunyin Xue, Jijuan Zhou, Guodong Zhong","doi":"10.24875/CIRU.23000580","DOIUrl":"https://doi.org/10.24875/CIRU.23000580","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to evaluate the effect of open reduction and internal fixation for displaced intra-articular calcaneal fractures through a modified tarsal sinus incision.</p><p><strong>Methods: </strong>A retrospective review over 3 years of the clinical data of patients with intra-articular calcaneal fractures treated with open reduction and internal fixation through lateral hook curvy incisions. The efficacy of the 25 lateral hook curvy incisions was analyzed.</p><p><strong>Results: </strong>According to the AOFAS hindfoot function scoring criteria, there were 20 excellent (80%), 2 good (8%), 2 fair (8%), and 1 poor patient outcome. The average pre-operative Bohler's angle was 6.8 ± 8.9°, and the average angle at follow-up was 33.6 ± 5.7°. The average pre-operative Gissane angle was 89.2 ± 20.0°, and the average angle at follow-up was 115.5 ± 5.5°.</p><p><strong>Conclusions: </strong>A lateral hook curvy incision can expose the posterior articular surface of the calcaneus and the calcaneocuboid joint, reduce stripping and pulling of the soft tissue, and avoid calcaneus valgus caused by the pulling of the peroneus tendon.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 5","pages":"608-617"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management guidelines in triplidemia due to respiratory viruses and the social importance of the clinical-genetic diagnosis algorithm of SARS-COV2. 呼吸道病毒引起的三联症管理指南和 SARS-COV2 临床基因诊断算法的社会意义。
Pub Date : 2024-01-01 DOI: 10.24875/CIRU.22000584
Sergio A Ramírez-García, Carlos E Cabrera-Pivaral, José Domínguez-Rodas, David A López-de la Mora, Sabina López-Toledo, Felicitas Ortiz-García, Reyna M Hernández-Vásquez, Diego A Cáceres-Gutiérrez
{"title":"Management guidelines in triplidemia due to respiratory viruses and the social importance of the clinical-genetic diagnosis algorithm of SARS-COV2.","authors":"Sergio A Ramírez-García, Carlos E Cabrera-Pivaral, José Domínguez-Rodas, David A López-de la Mora, Sabina López-Toledo, Felicitas Ortiz-García, Reyna M Hernández-Vásquez, Diego A Cáceres-Gutiérrez","doi":"10.24875/CIRU.22000584","DOIUrl":"https://doi.org/10.24875/CIRU.22000584","url":null,"abstract":"","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 5","pages":"693-695"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of US elastography and chemical shift magnetic resonance imaging in multifidus muscle fatty degeneration. 多裂肌脂肪变性的 US 弹性成像与化学位移磁共振成像的比较。
Pub Date : 2024-01-01 DOI: 10.24875/CIRU.24000048
Fatıh Kırcın, Bahar Yanık, Erdogan Bulbul, Emrah Akay, Gulen Demırpolat

Objective: The purpose of this study was to investigate the feasibility of the use of shear wave elastography (SWE) in comparison to chemical shift encoding (CSE) magnetic resonance imaging (MRI) for the evaluation of multifidus muscle fatty degeneration in patients with chronic low back pain.

Method: Multifidus muscles were evaluated with the CSE-MRI and SWE examinations in control and patient groups. With the in-phase and out-phase sequences in CSE-MRI, signal intensity index (SII), and signal intensity suppression ratio (SISR) values; with the SWE method, shear wave velocity values were determined. Differences in the mean values of these parameters per level and study group were analyzed by Student's t-test.

Results: SWE revealed significantly lower stiffness at the L2-3 level, consistent with the signal index values (SII-SISR) showing increased fatty infiltration on MRI in the patient group. No such relationship was found at the L4-5 level or in control group.

Conclusions: SWE may be a promising method to show muscle fatty infiltration at L2-3 level in patients with chronic low back pain.

研究目的本研究旨在探讨剪切波弹性成像(SWE)与化学位移编码(CSE)核磁共振成像(MRI)相比,用于评估慢性腰痛患者多裂肌脂肪变性的可行性:方法:用 CSE-MRI 和 SWE 检查评估对照组和患者组的多裂肌。采用 CSE-MRI 的相内和相外序列,测定信号强度指数(SII)和信号强度抑制比(SISR)值;采用 SWE 方法,测定剪切波速度值。通过学生 t 检验分析了各水平和研究组这些参数平均值的差异:结果:SWE 显示 L2-3 水平的硬度明显较低,这与 MRI 上显示患者组脂肪浸润增加的信号指数值(SII-SISR)一致。在 L4-5 水平或对照组中未发现这种关系:SWE可能是显示慢性腰痛患者L2-3水平肌肉脂肪浸润的一种有前途的方法。
{"title":"Comparison of US elastography and chemical shift magnetic resonance imaging in multifidus muscle fatty degeneration.","authors":"Fatıh Kırcın, Bahar Yanık, Erdogan Bulbul, Emrah Akay, Gulen Demırpolat","doi":"10.24875/CIRU.24000048","DOIUrl":"https://doi.org/10.24875/CIRU.24000048","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to investigate the feasibility of the use of shear wave elastography (SWE) in comparison to chemical shift encoding (CSE) magnetic resonance imaging (MRI) for the evaluation of multifidus muscle fatty degeneration in patients with chronic low back pain.</p><p><strong>Method: </strong>Multifidus muscles were evaluated with the CSE-MRI and SWE examinations in control and patient groups. With the in-phase and out-phase sequences in CSE-MRI, signal intensity index (SII), and signal intensity suppression ratio (SISR) values; with the SWE method, shear wave velocity values were determined. Differences in the mean values of these parameters per level and study group were analyzed by Student's t-test.</p><p><strong>Results: </strong>SWE revealed significantly lower stiffness at the L2-3 level, consistent with the signal index values (SII-SISR) showing increased fatty infiltration on MRI in the patient group. No such relationship was found at the L4-5 level or in control group.</p><p><strong>Conclusions: </strong>SWE may be a promising method to show muscle fatty infiltration at L2-3 level in patients with chronic low back pain.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 5","pages":"633-640"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute kidney injury and mortality in patients with critical COVID-19 in Mexico: case-control study. 墨西哥 COVID-19 重症患者的急性肾损伤和死亡率:病例对照研究。
Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000207
Ivette Mata-Maqueda, Juan C Solís-Sáinz, Guadalupe Zaldivar-Lelo de Larrea, Ernesto Deloya-Tomas, Jorge López-Fermín, Mª Guadalupe Olvera-Ramos, Gabriela Castillo-Gutiérrez, Jorge D Carrión-Moya, Orlando R Pérez-Nieto

Objective: We aimed to test the association between acute kidney injury (AKI) and mortality in critically ill patients with Coronavirus disease 2019 (COVID-19).

Method: We conducted a single-center case-control study at the intensive care unit (ICU) of a second-level hospital in Mexico. We included 100 patients with critical COVID-19 from January to December 2021, and collected demographic characteristics, comorbidities, APACHE II, SOFA, NEWS2, and CO-RADS scores at admission, incidence of intrahospital complications, length of hospital and ICU stay, and duration of mechanical ventilation, among others.

Results: The median survival of deceased patients was 20 days. After multivariable logistic regression, the following variables were significantly associated to mortality: AKI (adjusted odds ratio [AOR] 6.64, 95% confidence intervals [CI] = 2.1-20.6, p = 0.001), age > 55 years (AOR 5.3, 95% CI = 1.5-18.1, p = 0.007), and arrhythmias (AOR 5.15, 95% CI = 1.3-19.2, p = 0.015). Median survival was shorter in patients with AKI (15 vs. 22 days, p = 0.043), as well as in patients with overweight/obesity (15 vs. 25 days, p = 0.026).

Conclusion: Our findings show that the development of AKI was the main risk factor associated with mortality in critical COVID-19 patients, while other factors such as older age and cardiac arrhythmias were also associated with this outcome. The management of patients with COVID-19 should include renal function screening and staging on admission to the Emergency Department.

目的我们旨在检验2019年冠状病毒病(COVID-19)重症患者急性肾损伤(AKI)与死亡率之间的关联:我们在墨西哥一家二级医院的重症监护室(ICU)开展了一项单中心病例对照研究。我们纳入了2021年1月至12月的100名COVID-19危重症患者,收集了他们的人口统计学特征、合并症、入院时的APACHE II、SOFA、NEWS2和CO-RADS评分、院内并发症发生率、住院时间和ICU住院时间、机械通气持续时间等:死亡患者的中位生存期为 20 天。经过多变量逻辑回归,以下变量与死亡率有显著相关性:AKI(调整后比值比 [AOR] 6.64,95% 置信区间 [CI] = 2.1-20.6,P = 0.001)、年龄大于 55 岁(AOR 5.3,95% CI = 1.5-18.1,P = 0.007)和心律失常(AOR 5.15,95% CI = 1.3-19.2,P = 0.015)。AKI患者的中位生存期较短(15天 vs. 22天,p = 0.043),超重/肥胖患者的中位生存期也较短(15天 vs. 25天,p = 0.026):我们的研究结果表明,发生 AKI 是与 COVID-19 危重患者死亡率相关的主要风险因素,而其他因素如年龄较大和心律失常也与这一结果有关。对 COVID-19 患者的管理应包括肾功能筛查和急诊科入院分期。
{"title":"Acute kidney injury and mortality in patients with critical COVID-19 in Mexico: case-control study.","authors":"Ivette Mata-Maqueda, Juan C Solís-Sáinz, Guadalupe Zaldivar-Lelo de Larrea, Ernesto Deloya-Tomas, Jorge López-Fermín, Mª Guadalupe Olvera-Ramos, Gabriela Castillo-Gutiérrez, Jorge D Carrión-Moya, Orlando R Pérez-Nieto","doi":"10.24875/CIRU.23000207","DOIUrl":"https://doi.org/10.24875/CIRU.23000207","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to test the association between acute kidney injury (AKI) and mortality in critically ill patients with Coronavirus disease 2019 (COVID-19).</p><p><strong>Method: </strong>We conducted a single-center case-control study at the intensive care unit (ICU) of a second-level hospital in Mexico. We included 100 patients with critical COVID-19 from January to December 2021, and collected demographic characteristics, comorbidities, APACHE II, SOFA, NEWS2, and CO-RADS scores at admission, incidence of intrahospital complications, length of hospital and ICU stay, and duration of mechanical ventilation, among others.</p><p><strong>Results: </strong>The median survival of deceased patients was 20 days. After multivariable logistic regression, the following variables were significantly associated to mortality: AKI (adjusted odds ratio [AOR] 6.64, 95% confidence intervals [CI] = 2.1-20.6, p = 0.001), age > 55 years (AOR 5.3, 95% CI = 1.5-18.1, p = 0.007), and arrhythmias (AOR 5.15, 95% CI = 1.3-19.2, p = 0.015). Median survival was shorter in patients with AKI (15 vs. 22 days, p = 0.043), as well as in patients with overweight/obesity (15 vs. 25 days, p = 0.026).</p><p><strong>Conclusion: </strong>Our findings show that the development of AKI was the main risk factor associated with mortality in critical COVID-19 patients, while other factors such as older age and cardiac arrhythmias were also associated with this outcome. The management of patients with COVID-19 should include renal function screening and staging on admission to the Emergency Department.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 5","pages":"626-632"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutritional care of the patient after metabolic surgery: a misunderstood discipline. 代谢手术后患者的营养护理:一门被误解的学科。
Pub Date : 2024-01-01 DOI: 10.24875/CIRU.22000515
Emily S Valadez-Méndez, Sol Ramírez-Ochoa, Leonardo Perales-Guerrero, Shaúl A Navarro-Lara, Liliana B Alcázar-García, Carlos J Moreno-Bernardino, Javier Solís-Estrada, Silvia G Esquivel-Razo, Miguel A Buenrostro-Ahued, Enrique Cervantes-Pérez
{"title":"Nutritional care of the patient after metabolic surgery: a misunderstood discipline.","authors":"Emily S Valadez-Méndez, Sol Ramírez-Ochoa, Leonardo Perales-Guerrero, Shaúl A Navarro-Lara, Liliana B Alcázar-García, Carlos J Moreno-Bernardino, Javier Solís-Estrada, Silvia G Esquivel-Razo, Miguel A Buenrostro-Ahued, Enrique Cervantes-Pérez","doi":"10.24875/CIRU.22000515","DOIUrl":"https://doi.org/10.24875/CIRU.22000515","url":null,"abstract":"","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 6","pages":"839-840"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142735280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of antiangiogenic agent aflibercept on surgically induced endometriosis in a rat model. 抗血管生成剂 aflibercept 对手术诱发的大鼠子宫内膜异位症的影响。
Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000072
Caglayan Ates, Berna Dilbaz, Seval Yılmaz Ergani, Fuad Atabay

Objective: The aim of the study is to show for the first time how aflibercept affects endometriosis lesions.

Material and methods: Surgically induced endometriosis in Wistar albino female rats. Rats with endometriosis were randomly divided into three groups: control (Co), aflibercept (Af), and leuprolide acetate (Le). Then, Af, aflibercept, and Le received leuprolide acetate. The control group was not treated. The weights and changes in intra-abdominal adhesions of the rats before and after treatment were recorded according to the Blauer adhesion score. Blood extracted for sacrifice was analyzed. Endometriotic lesions were evaluated for size, volume, histology, and immunohistochemistry (vascular endothelial growth factor [VEGF] and CD31). Significance level was accepted as p < 0.05.

Results: Aflibercept significantly reduced endometrial implant volume (p = 0.002). The explant epithelial histological score showed a significant difference between aflibercept and leuprolide acetate (p = 0.006) and between aflibercept and control groups (p = 0.002). Aflibercept decreased VEGF-H and CD31 expression (p = 0.001) more than leuprolide acetate. Aflibercept improved adhesions (p = 0.006).

Conclusion: Aflibercept is more successful than leuprolide acetate in the treatment of endometriosis.

研究目的本研究旨在首次展示阿弗利百普对子宫内膜异位症病变的影响:手术诱导Wistar白化雌性大鼠患子宫内膜异位症。将患有子宫内膜异位症的大鼠随机分为三组:对照组(Co)、阿弗利百普(aflibercept)组(Af)和醋酸亮丙瑞林(Le)组。然后,Af、aflibercept 和 Le 组接受醋酸亮丙瑞林治疗。对照组未接受治疗。根据布劳尔粘连评分记录治疗前后大鼠的体重和腹腔内粘连的变化。对牺牲时抽取的血液进行分析。对子宫内膜异位病变的大小、体积、组织学和免疫组化(血管内皮生长因子 [VEGF] 和 CD31)进行评估。P<0.05为显著性水平:结果:阿弗利百普能明显减少子宫内膜植入物的体积(p = 0.002)。阿弗利百普与醋酸亮丙瑞林组(P = 0.006)以及阿弗利百普与对照组(P = 0.002)的外植体上皮组织学评分差异显著。与醋酸亮丙瑞林相比,阿弗利百普能减少血管内皮生长因子-H和CD31的表达(p = 0.001)。Aflibercept改善了粘连(p = 0.006):结论:阿弗利百普治疗子宫内膜异位症比醋酸亮丙瑞林更成功。
{"title":"The effect of antiangiogenic agent aflibercept on surgically induced endometriosis in a rat model.","authors":"Caglayan Ates, Berna Dilbaz, Seval Yılmaz Ergani, Fuad Atabay","doi":"10.24875/CIRU.23000072","DOIUrl":"10.24875/CIRU.23000072","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study is to show for the first time how aflibercept affects endometriosis lesions.</p><p><strong>Material and methods: </strong>Surgically induced endometriosis in Wistar albino female rats. Rats with endometriosis were randomly divided into three groups: control (Co), aflibercept (Af), and leuprolide acetate (Le). Then, Af, aflibercept, and Le received leuprolide acetate. The control group was not treated. The weights and changes in intra-abdominal adhesions of the rats before and after treatment were recorded according to the Blauer adhesion score. Blood extracted for sacrifice was analyzed. Endometriotic lesions were evaluated for size, volume, histology, and immunohistochemistry (vascular endothelial growth factor [VEGF] and CD31). Significance level was accepted as p < 0.05.</p><p><strong>Results: </strong>Aflibercept significantly reduced endometrial implant volume (p = 0.002). The explant epithelial histological score showed a significant difference between aflibercept and leuprolide acetate (p = 0.006) and between aflibercept and control groups (p = 0.002). Aflibercept decreased VEGF-H and CD31 expression (p = 0.001) more than leuprolide acetate. Aflibercept improved adhesions (p = 0.006).</p><p><strong>Conclusion: </strong>Aflibercept is more successful than leuprolide acetate in the treatment of endometriosis.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 1","pages":"10-19"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for readmission after a cholecystectomy: a case-control study. 胆囊切除术后再次入院的风险因素:病例对照研究。
Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000057
Daniel Garcia, Antonia Pastore, Javier Rodriguez, Fernando Crovari, Jaime Cerda, Patricia Rebolledo, Pablo Achurra, Eduardo Viñuela, Jorge Martinez, Martin Dib, Eduardo Briceño

Objective: The aim of this study was to assess the risk factors associated with 30-day hospital readmissions after a cholecystectomy.

Methods: We conducted a case-control study, with data obtained from UC-Christus from Santiago, Chile. All patients who underwent a cholecystectomy between January 2015 and December 2019 were included in the study. We identified all patients readmitted after a cholecystectomy and compared them with a randomized control group. Univariate and multivariate analyses were conducted to identify risk factors.

Results: Of the 4866 cholecystectomies performed between 2015 and 2019, 79 patients presented 30-day hospital readmission after the surgical procedure (1.6%). We identified as risk factors for readmission in the univariate analysis the presence of a solid tumor at the moment of cholecystectomy (OR = 7.58), high pre-operative direct bilirubin (OR = 2.52), high pre-operative alkaline phosphatase (OR = 3.25), emergency admission (OR = 2.04), choledocholithiasis on admission (OR = 4.34), additional surgical procedure during the cholecystectomy (OR = 4.12), and post-operative complications. In the multivariate analysis, the performance of an additional surgical procedure during cholecystectomy was statistically significant (OR = 4.24).

Conclusion: Performing an additional surgical procedure during cholecystectomy was identified as a risk factor associated with 30-day hospital readmission.

研究目的本研究旨在评估与胆囊切除术后 30 天再住院相关的风险因素:我们进行了一项病例对照研究,数据来自智利圣地亚哥的 UC-Christus。所有在2015年1月至2019年12月期间接受胆囊切除术的患者都被纳入研究范围。我们确定了所有胆囊切除术后再次入院的患者,并将他们与随机对照组进行了比较。我们进行了单变量和多变量分析,以确定风险因素:在2015年至2019年期间进行的4866例胆囊切除术中,有79名患者在手术后30天内再次入院(1.6%)。在单变量分析中,我们将以下因素确定为再入院的风险因素:胆囊切除术时存在实体瘤(OR = 7.58)、术前直接胆红素高(OR = 2.52)、术前碱性磷酸酶高(OR = 3.25)、急诊入院(OR = 2.04)、入院时有胆总管结石(OR = 4.34)、胆囊切除术期间有额外的外科手术(OR = 4.12)以及术后并发症。在多变量分析中,胆囊切除术中进行额外手术具有统计学意义(OR = 4.24):结论:在胆囊切除术中进行额外的外科手术被认为是与 30 天再入院相关的风险因素。
{"title":"Risk factors for readmission after a cholecystectomy: a case-control study.","authors":"Daniel Garcia, Antonia Pastore, Javier Rodriguez, Fernando Crovari, Jaime Cerda, Patricia Rebolledo, Pablo Achurra, Eduardo Viñuela, Jorge Martinez, Martin Dib, Eduardo Briceño","doi":"10.24875/CIRU.23000057","DOIUrl":"10.24875/CIRU.23000057","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to assess the risk factors associated with 30-day hospital readmissions after a cholecystectomy.</p><p><strong>Methods: </strong>We conducted a case-control study, with data obtained from UC-Christus from Santiago, Chile. All patients who underwent a cholecystectomy between January 2015 and December 2019 were included in the study. We identified all patients readmitted after a cholecystectomy and compared them with a randomized control group. Univariate and multivariate analyses were conducted to identify risk factors.</p><p><strong>Results: </strong>Of the 4866 cholecystectomies performed between 2015 and 2019, 79 patients presented 30-day hospital readmission after the surgical procedure (1.6%). We identified as risk factors for readmission in the univariate analysis the presence of a solid tumor at the moment of cholecystectomy (OR = 7.58), high pre-operative direct bilirubin (OR = 2.52), high pre-operative alkaline phosphatase (OR = 3.25), emergency admission (OR = 2.04), choledocholithiasis on admission (OR = 4.34), additional surgical procedure during the cholecystectomy (OR = 4.12), and post-operative complications. In the multivariate analysis, the performance of an additional surgical procedure during cholecystectomy was statistically significant (OR = 4.24).</p><p><strong>Conclusion: </strong>Performing an additional surgical procedure during cholecystectomy was identified as a risk factor associated with 30-day hospital readmission.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 1","pages":"3-9"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing complex decongestive therapy in patients with lymphedema of different causes by measuring: extremity volume, quality of life, and functionality. 通过测量肢体体积、生活质量和功能,比较不同原因引起的淋巴水肿患者的复合减充血疗法。
Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000330
Cansu Sahbaz-Pirincci, Emine Cihan, Ülkü Düzlü-Öztürk, Pınar Borman, Meltem Dalyan

Objective: This study aimed to investigate the effects of complex decongestive therapy (CDT) applied to the lower extremities of patients with lymphedema of different causes on the extremity volume, quality of life (QoL), and functionality.

Materials and method: The study included 90 patients, of whom 28 had primary lymphedema, 30 had secondary lymphedema, 18 had phlebolymphedema, and 14 had lipolymphedema. A total of 137 extremities were treated with CDT. The patients who received CDT for 5 days a week for 3 weeks (15 sessions in total) were included in the sample. Extremity volume was measured using a tape measure. The lymphedema QoL-Leg Questionnaire was used to evaluate QoL, and the lower extremity functional scale (LEFS) was administered to assess lower extremity functionality.

Results: The changes in QoL before and after treatment significantly differed in the primary lymphedema, phlebolymphedema, and lipolymphedema groups (p < 0.05). The post-treatment LEFS scores indicated a significant decrease in the phlebolymphedema and lipolymphedema groups compared to the pre-treatment scores (p < 0.05).

Conclusions: The difference in appearance, which is one of the sub-parameters of QoL, significantly decreased in the comparisons performed between the groups, whereas the changes in the remaining parameters were not significant.

研究目的本研究旨在探讨对不同原因引起的淋巴水肿患者的下肢应用复合去充血疗法(CDT)对其肢体体积、生活质量(QoL)和功能的影响:研究包括 90 名患者,其中 28 人患有原发性淋巴水肿,30 人患有继发性淋巴水肿,18 人患有噬脂性淋巴水肿,14 人患有脂肪性淋巴水肿。共有 137 个肢体接受了 CDT 治疗。接受 CDT 治疗的患者每周 5 天,为期 3 周(共 15 次治疗)。使用卷尺测量肢体体积。淋巴水肿QoL-腿部问卷用于评估QoL,下肢功能量表(LEFS)用于评估下肢功能:结果:原发性淋巴水肿组、噬脂性淋巴水肿组和脂肪性淋巴水肿组治疗前后的 QoL 变化有显著差异(P < 0.05)。治疗后LEFS评分显示,与治疗前相比,咽喉水肿组和脂肪性水肿组的LEFS评分明显下降(P < 0.05):结论:在各组间进行的比较中,作为生活质量子参数之一的外观差异显著减少,而其余参数的变化并不明显。
{"title":"Comparing complex decongestive therapy in patients with lymphedema of different causes by measuring: extremity volume, quality of life, and functionality.","authors":"Cansu Sahbaz-Pirincci, Emine Cihan, Ülkü Düzlü-Öztürk, Pınar Borman, Meltem Dalyan","doi":"10.24875/CIRU.23000330","DOIUrl":"https://doi.org/10.24875/CIRU.23000330","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the effects of complex decongestive therapy (CDT) applied to the lower extremities of patients with lymphedema of different causes on the extremity volume, quality of life (QoL), and functionality.</p><p><strong>Materials and method: </strong>The study included 90 patients, of whom 28 had primary lymphedema, 30 had secondary lymphedema, 18 had phlebolymphedema, and 14 had lipolymphedema. A total of 137 extremities were treated with CDT. The patients who received CDT for 5 days a week for 3 weeks (15 sessions in total) were included in the sample. Extremity volume was measured using a tape measure. The lymphedema QoL-Leg Questionnaire was used to evaluate QoL, and the lower extremity functional scale (LEFS) was administered to assess lower extremity functionality.</p><p><strong>Results: </strong>The changes in QoL before and after treatment significantly differed in the primary lymphedema, phlebolymphedema, and lipolymphedema groups (p < 0.05). The post-treatment LEFS scores indicated a significant decrease in the phlebolymphedema and lipolymphedema groups compared to the pre-treatment scores (p < 0.05).</p><p><strong>Conclusions: </strong>The difference in appearance, which is one of the sub-parameters of QoL, significantly decreased in the comparisons performed between the groups, whereas the changes in the remaining parameters were not significant.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 3","pages":"354-361"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cirugia y cirujanos
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1